Quality of life and physicians' perception in myelodysplastic syndromes.Oliva En, Spiriti Ma, Carlo Finelli et al.|PubMed|2012Cited by 51
Iron‐chelating therapy with deferasirox in transfusion‐dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre studyPellegrino Musto, Alessandro Levis, Luca Maurillo et al.|British Journal of Haematology|2017Cited by 25
Ponatinib Is Well Tolerated and Active In Patients With Relapsed/Refractory Philadelphia Positive Acute Lymphoblastic Leukemia (PH+ ALL) and Advanced Phase Of Chronic Myelogenous Leukemia (CML) Harbouring T315I Mutation: The Bologna ExperienceCristina Papayannidis, Giovanni Martinelli, Maria Teresa Bochicchio et al.|Blood|2013Cited by 1